New data clarify leaflet thickening in TAVI and surgical aortic prostheses

May 21, 2015, EuroPCR

New data released today at EuroPCR 2015 suggest that thickening of the valve leaflets following implantation of a transcatheter or surgical aortic valve bioprosthesis is relatively rare, not linked to short-term clinical events, and not unique to any one type of valve. Longer-term follow-up and larger studies looking specifically at this issue are warranted, experts said here at a special session devoted to the emerging understanding of the phenomenon.

"At the present time, there is no evidence to support a change in patient selection, procedural aspects, or post-procedural management for (TAVI) or surgical (SAVR)," said Dr. Lars S√łndergaard of Rigshospitalet, Denmark, who led one of the leaflet studies. "But the findings call for further studies."

Well over 100,000 transcatheter implantation procedures have been performed worldwide, making the minimally invasive procedure a standard therapy for patients with inoperable , as well as for high-risk patients who are eligible for conventional surgery. In September 2014, imaging studies used in a US-based trial of a TAVI device identified thickening and reduced mobility of the device leaflet following implantation, prompting concerns that this phenomenon could have adverse clinical effects for the valve recipients. As a precaution, the trial was paused.

"In the short term we have not seen clinical consequences such as strokes, but larger and longer term studies are needed," said Dr. Raj Makkar, associate director at Cedars Sinai Heart Institute, and author of another featured study. "These imaging findings should be looked at in the context of robust clinical trial data that is available on the efficacy of TAVI and SAVR."

During today's session, researchers presented results from three separate, single-centre studies providing insights from a total of 345 patients treated with a range of transcatheter or surgical valves. Among the insights:

  • CT and echocardiographic imaging at 5 days, 30 days, or at later time points, depending on the study, found a spectrum of abnormalities including hypo-attenuated leaflet thickening, impaired leaflet motion, and thin films or small aggregations believed to be thrombus, in 7-15% of patients.
  • Abnormalities detected on imaging were not unique to a particular surgical or transcatheter valve.
  • Leaflet abnormalities were not associated with clinical events (stroke, systemic embolism, or valve failure), although follow-up, so far, has been short.
  • Most advanced abnormalities resolved with the use of oral anticoagulants, although patient selection, anticoagulant type, and anticoagulant dose have not been established.

"The findings remind us that evidence is lacking for the current focus on antiplatelet therapy for newly implanted aortic bioprotheses," said Dr. Franz-Josef Neumann, medical director for the Department of Cardiology and Angiology II, University Heart Center Freiburg, Bad Krozingen, and lead author on the third study. "Nevertheless, it may be difficult to make advances, given the low level of risk that we have achieved already."

Dr. Bernard Prendergast, session co-chair and co-director of PCR London Valves as well as director of the Cardiac Structural Intervention Programme at Guys and St Thomas' Trust in London, UK, commented "TAVI is an established life saving procedure with a wealth of high quality clinical evidence demonstrating its safety, durability and effectiveness. The reassuring data presented today indicate that there is no need for clinicians to adjust their practice in relation to patient selection, performance of the TAVI procedure, or follow up protocols, including post-procedural imaging and anti-thrombotic therapy."

Explore further: TAVI, safe and effective as surgical valves at two years in lower risk patients

More information: Associated EuroPCR 2015 Session: Breaking news: leaflet thickening and reduced motion of biosprosthetic aortic valves, 8:15-9:50 CEST, Thursday May 21, Main Arena

Related Stories

TAVI, safe and effective as surgical valves at two years in lower risk patients

May 19, 2015
Two year outcomes in a study comparing implantation of transcatheter and surgical bioprosthestic aortic valves shows that the less invasive procedure is safe and effective, and comparable to the gold standard, surgical valve ...

MDCT helps better determine valve implant size for transcatheter aortic valve in patients with aortic stenosis

April 13, 2013
MDCT is a better way to measure annular size in patients with aortic stenosis who are candidates for transcatheter aortic valve implantation (TAVI) than two dimensional echocardiography, a new study indicates.

Results of the STACCATO Trial reported at TCT 2011

November 10, 2011
Researchers leading a clinical trial said that transapical transcatheter aortic valve implantation (a-TAVI) may be inferior to surgical aortic valve replacement (SAVR) in operable elderly patients. However results were only ...

Retrievable transcatheter aortic valve effective and safe in real world setting

August 31, 2014
A retrievable and repositionable transcatheter aortic valve is effective and safe in a real world setting, according to research presented at ESC Congress 2014 today by Dr Stylianos Pyxaras from Germany. The direct flow medical ...

TAVI is safe alternative to redo cardiac surgery

September 2, 2013
TAVI is a safe alternative to redo cardiac surgery for failing bioprosthetic valves, according to research presented at the ESC Congress today by Dr. Spyridon Katsanos from the Netherlands. The findings suggest that transcatheter ...

Recommended for you

Gut protein mutations shield against spikes in glucose

November 20, 2018
Why is it that, despite consuming the same number of calories, sodium and sugar, some people face little risk of diabetes or obesity while others are at higher risk? A new study by investigators at Brigham and Women's Hospital ...

Proteins cooperate to break up energy structures in oxygen starved heart cells

November 19, 2018
During a heart attack, the supply of oxygen to heart cells is decreased. This reduced oxygen level, called hypoxia, causes the cell's powerhouses, the mitochondria, to fragment, impairing cell function and leading to heart ...

Bullying and violence at work increases the risk of cardiovascular disease

November 19, 2018
People who are bullied at work or experience violence at work are at higher risk of heart and brain blood vessel problems, including heart attacks and stroke, according to the largest prospective study to investigate the ...

Genetic analysis links obesity with diabetes, coronary artery disease

November 16, 2018
A Cleveland Clinic genetic analysis has found that obesity itself, not just the adverse health effects associated with it, significantly increases the risk of Type 2 diabetes and coronary artery disease. The paper was published ...

Non-coding genetic variant could improve key vascular functions

November 15, 2018
Atherosclerotic disease, the slow and silent hardening and narrowing of the arteries, is a leading cause of mortality worldwide. It is responsible for more than 15 million deaths each year, including an estimated 610,000 ...

Study of two tribes sheds light on role of Western-influenced diet in blood pressure

November 14, 2018
A South American tribe living in near-total isolation with no Western dietary influences showed no increase in average blood pressure from age one to age 60, according to a study led by researchers at Johns Hopkins Bloomberg ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.